Insights

Insight

The age of Precision Medicine

These are heady days at the R&D end of healthcare with what seems like a constant drip-feed o...

Insight

Laying down a biomarker

It might come as something of a surprise to learn that no less than 60 per cent of the 5,600-plus...

Insight

What next for Medtech?

Change is inevitable in any organisation whether you will it or don’t. The question is whether th...